Neochromosome, Inc.
Cierra Sing is currently a Scientist I at Neochromosome, Inc., with previous experience as a Postdoctoral Researcher and PhD Candidate in Dr. Liza Pon's Laboratory at Columbia University Vagelos College of Physicians and Surgeons. Sing's research includes discovering a novel protein regulating the actin cytoskeleton and studying age-associated functional decline in Saccharomyces cerevisiae, alongside publishing multiple first-author works and co-authoring additional publications. Prior roles include research assistant positions at Johns Hopkins Bloomberg School of Public Health and MedImmune Vaccines, with a focus on nutritional impact on childhood diseases and vaccine development, respectively. Sing holds a PhD in Nutritional and Metabolic Biology, a ScM in Molecular Microbiology and Immunology, and a BA in Biochemistry & Molecular Cell Biology.
This person is not in any teams
Neochromosome, Inc.
At Neochromosome, we enable biological engineering at a genome-scale. Our partners use our groundbreaking synthetic DNA and cell engineering services to investigate novel therapeutics, develop more sustainable products, and conduct pioneering scientific research. Neochromosome is uniquely suited to accelerate this work. Our first-in-class capabilities were developed to design, build, and test the world's first fully synthetic eukaryotic cells. Today, we offer our services and platform -- from highly automated synthesis of complex DNA to de novo design, synthesis, and delivery of chromosomes – to researchers around the world.